Not sure how legit this is, but I found this: http://innovativemen.com/topical-fin...tment-seattle/
Link to Topical Finasteride
Collapse
X
-
Tags: None
-
The website looks well-made, unlike some hair loss products websites I have seen that look like they were made by a 6 year old with Microsoft Paint. But I rather wait a little while to see if a reputable company comes out with topical fin.Comment
-
-
-
-
the worst part is inspite of all the combinations there is nothing that really helps my hair w/o sides, feel like im cursedComment
-
-
I made my own topical dutasteride solution by crushing some pills into a premade rogaine solution. It had no effect. However, finasteride has a lower molecular weight than dutasteride (372.55 vs 528.53 g/mol) so maybe it would work better .Comment
-
Topical Finasteride is very interesting indeed, however I still need to see it to be sold officially in pharmacies and drugstores. By then I will give it a try as oral Finasteride gave me great results but a lot of sexual sides. I hope the topical formula will solve the libidio issue somehow.Comment
-
This was presented at the 7th world congress of hair research:
P040
Pharmacodynamic of P-3074 (finasteride 0.25% topical solution) in subjects with
androgenetic alopecia
M Caserini1, R Palmieri1, M Radicioni2 and E Terragni2 1Polichem S.A., Lugano, Switzerland and
2Cross Research S.A., Arzo, Switzerland
A new proprietary topical formulation, P-3074, containing finasteride 0.25% as active ingredient
and hydroxypropyl-chitosan (HPCH) as film-forming agent, was developed for androgenetic
alopecia. The present study was aimed at investigating the pharmacodynamic profile of
finasteride in terms of dihydrotestosterone (DHT) concentrations in the scalp and in serum after
multiple topical application of P-3074 or oral finasteride intake in subjects with androgenetic
alopecia. Eighteen healthy men were randomly allocated to P-3074 or oral treatment after
providing written informed consent. Twelve volunteers applied P-3074 topical solution for 7
days: six subjects once daily (o.d.) in the morning and the others twice daily (b.i.d.) in the morning
and in the evening. The third group of six volunteers was administered 1mg oral finasteride once
daily in the morning for 1 week. Scalp (vertex) biopsies were collected at baseline and 6 hours
after last dose administration, while serum samples were collected at baseline, before last
administration, and 6 and 12 hours after the last multiple dose.
A marked decrease in scalp DHT levels was observed:
by 47.22% with P-3074 b.i.d., from 1.91 (±0.54) to 1.01 ng ml1 (±0.39),
by 71.20% with P-3074 o.d., from 1.52 (±0.41) to 0.44 ng ml1 (±0.0, and
by 51.11% with the oral formulation, from 1.39 (±0.25) to 0.68 ng ml1 (±0.34).
Serum DHT was reduced by
69.3–74.0% with P-3074 b.i.d., 67.6–80.4% with P-3074 o.d., and
69.7–76.1% with the oral formulation.
These results showed a similar inhibition of serum DHT after 1 week of finasteride
administration with the three dose regimens and were consistent with the results obtained in a
previous P-3074 PK study. These findings show that DHT concentration in the scalp, after 7-day
treatment course of P-3074 o.d., was more reduced (about 40%) than after 1mg oral finasteride
administration for the same treatment periodComment
-
Comment
Comment